Similar Posts
Rare Diseases Are Becoming Too Common. Sound Impossible? Here's Why It's Not
ByadminIt is hard to make money treating rare diseases. There simply aren’t enough customers to generate many profits. That’s why the U.S. government passed the Orphan Drug Act in 1983, a law which created a series of incentives to encourage drug companies to develop treatments for rare or “orphan” diseases – conditions affecting less than…
Who’s Paying Out-of-Pocket for Medical Care
ByadminMany Americans are buying healthcare insurance that asks them to pay a lot, out-of-pocket, for the care they receive. It looks like that trend, towards higher expenses, is especially common among higher income folks, as shown by this picture courtesy of the Commonwealth Fund:
The Future of Disease – in One Picture
ByadminHere are some projections on what illnesses Medicare enrollees are experiencing now, and what they will be experiencing 20 years from now, courtesy of the Brookings Institute:
Sagan the Quipster
ByadminIn 1996, a man wrote to Carl Sagan asking him the distance to heaven. Sagan was a very public agnostic. He replied brilliantly: “Thanks for your letter. Nothing like the Christian notion of heaven has been found out to about 10 billion light years. (One light year is almost six trillion miles.) With best wishes…”…
Will Lowering The Price Of Genetic Testing Raise The Cost Of Medical Care?
ByadminThe first time scientists sequenced a person’s entire genome, it took more than a decade and cost hundreds of millions of dollars. Currently, such sequencing takes less than twenty-four hours and costs less than $5,000: To put that into perspective, Myriad Genetics charges $3,000 to test for mutations in just two genes associated with breast…
Full Disclosure — Out-of-Pocket Costs as Side Effects
Byadmin“Full Disclosure — Out-of-Pocket Costs as Side Effects” – The New England Journal of Medicine

